From: RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study
Responders (Choi)
Non-Responders (Choi)
Total
SD (RECIST 1.1)
11
9
20
PD (RECIST 1.1)
7
8
15
18
17
35